Santen Pharmaceutical Co., Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SNPHY | OGN | BIIB | NVS | AZN | AMGN | |
|---|---|---|---|---|---|---|
| Market cap | 3.50B | 3.61B | 34.43B | 285.72B | 256.13B | 231.26B |
| P/E (TTM) | 14.1 | 17.6 | 41.4 | 22.7 | 23.7 | 26.6 |
| Forward P/E | 14.9 | 3.8 | 14.1 | 15.3 | 14.6 | 17.5 |
| Price/book | 1.8 | 3.6 | 1.8 | 6.9 | 5.1 | 19.8 |
| Dividend yield | 2.19% | 0.58% | — | 3.15% | 1.94% | 2.33% |
| 1-year change | +6.55% | +48.92% | +58.66% | +14.29% | −1.39% | +42.58% |
| Today | +0.46% | −0.11% | +0.16% | −0.20% | −0.16% | −1.10% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All SNPHY news ›SpyGlass Pharma, Inc. acquired Advanced Vision Science, Inc. from Santen Pharmaceutical Co., Ltd. for $13 million.
SpyGlass Pharma, Inc. (NasdaqGS:SGP) acquired Advanced Vision Science, Inc. from Santen Pharmaceutical Co., Ltd. (TSE:4536) for $13 million on October 1, 2026. A cash consideration of $13 million will ... (NasdaqGS:SGP) acquired Advanced…
Santen Pharmaceutical Co., Ltd. Stock (4536) - Quote Japan Exchange
Santen Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, and sale of pharmaceuticals. The Company engages in global research and development, manufacture, sale, and marketing of…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com2
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.